Average Insider

Where insiders trade, we follow

$ANTX
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Healthcare
Sector
Biotechnology
Industry
Eric E. Easom
CEO
22
Employees
$5.96
Current Price
$29.05M
Market Cap
52W Low$1.00
Current$5.9680.1% above low, 19.9% below high
52W High$7.19

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells12$212,702.3035,402
2 weeksBuys00--All Sells
Sells12$212,702.3035,402
1 monthBuys00--All Sells
Sells12$212,702.3035,402
2 monthsBuys00--All Sells
Sells23$237,504.8441,347
3 monthsBuys00--All Sells
Sells34$238,678.7941,612
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 17, 2026
Readnour Robin Shane
Director
Sale16,696$6.01$100,312.91View Details
Aug 17, 2026
Readnour Robin Shane
Director
Sale18,706$6.01$112,389.39View Details
Jul 8, 2026
Eizen Joshua M
Chief Operating Officer and Chief Legal Officer
Sale5,945$4.17$24,802.54View Details
May 29, 2026
Williams Sarah Joanne
Principal Accounting Officer
Sale265$4.43$1,173.95View Details
11 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3